Institutional Investors Increase Stakes in Elicio Therapeutics
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
What happened
Institutional investors have recently increased their positions in shares of Elicio Therapeutics, Inc. reports that Renaissance Technologies LLC grew its stake in the company by 332.7% during the first quarter. Additionally, BlackRock Inc. bought a new stake in Elicio Therapeutics during the second quarter, and Deutsche Bank AG also acquired a new stake during the second quarter, according to.
From themarketsdaily.com
Why it matters
The increased investment activity by major financial firms suggests growing institutional confidence in Elicio Therapeutics, Inc. This capital movement could influence market demand and the valuation of the company's stock.
From themarketsdaily.com
Who's involved
- Renaissance TechnologiesAmerican hedge fund firm that grew its investment stake in Elicio Therapeutics, Inc.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Renaissance TechnologiesSpeculative
Renaissance Technologies LLC might see changes in the cost of investment or returns on its portfolio.
Keep exploring
The entities involved
-
Renaissance Technologies
American hedge fund firm
Related events
- Renaissance Technologies holds a significant stake in Lite Strategy, Inc., whose stock trades on the Nasdaq exchange.
- Renaissance Technologies acquired shares listed on Nasdaq on August 16, 2026.
- Renaissance Technologies raised its stake in Alpha Pro Tech on September 4, 2026.
- Renaissance Technologies acquired a new stake in CN Energy Group, a company that trades on the Nasdaq stock exchange.
- Renaissance Technologies bought a new stake in Arqit Quantum Inc. on July 2, 2026.